Galderma

We are delighted to announce that results from our phase III trial on the treatment of crow’s feet have been published in Dermatologic Surgery. Many thanks to all the investigators and participants for your time and commitment to this study! Read the full publication here: https://bit.ly/3BHSLbT

Training and education make up one of our core tenets at Galderma. Through the Galderma Aesthetic Injector Network (GAIN) platform, we deliver best-in-class training on the latest trends, technologies and techniques in aesthetics. In 2024 alone, we trained over 88,000 practitioners at the more than 8,000 events we hosted around the world. And this year, we’ve raised the bar. By aligning GAIN with our groundbreaking trend report, NEXT by Galderma, we are helping injectors adapt to new and emerging trends, meet evolving patient demands – and continue delivering exceptional results. As the demand for aesthetic treatments continues to grow worldwide, we remain committed to bridging the gap between insight and practice. It’s one of the key ways that we deliver on our purpose: advancing dermatology for every skin story. Read more about how we have integrated NEXT into GAIN trainings here: https://lnkd.in/di9g96-E #AdvancingDermatology #GAINbyGalderma #NEXTbyGalderma

Have you seen our interview series uncovering the latest innovations behind beautiful, healthy skin? Beauty x Medicine explores the future of dermatology through eye-opening discussions with  top experts in the field, conducted by our CEO, Flemming Ornskov, MD, MPH. In each episode, guests such as Dr. Shawn Kwatra, Dr. Stephanie Lam and Dr. Christoph Martschin, MD discuss topics from therapeutic breakthroughs to enhancing aesthetic treatments through cutting-edge science. You can now listen to Beauty x Medicine as a podcast on Spotify! https://lnkd.in/eKp6VySQ Look out for new episodes in 2025, when we will continue advancing dermatology for every skin story by delivering fresh insights from leading voices. #AdvancingDermatology #BeautyXMedicine

We are very proud to share the news that our novel biologic has received approval from the United States (U.S.) Food and Drug Administration (FDA) for the treatment of moderate-to-severe #AtopicDermatitis in patients 12 years of age and older, marking its second U.S. approval this year, and further expanding the impact of our Therapeutic Dermatology franchise.   Approximately 7% of the U.S. population live with this condition, which has a significant negative impact on their lives. Atopic dermatitis is commonly characterized by uncomfortable skin lesions and persistent itch, which the majority of patients consider one of the most problematic symptoms of the disease.   Learn more about what this means here: https://lnkd.in/gFK3UZvB   #AdvancingDermatology #SkinScienceByGalderma

We are excited to announce that we have received a positive opinion from the European Medicines Agency’s CHMP for our investigational treatment in #PrurigoNodularis and #AtopicDermatitis.    This is a big step forward for people in the EU who suffer from these debilitating skin conditions.     Learn more about this exciting milestone here.  https://lnkd.in/egypiNJ8   #AdvancingDermatology #SkinScienceByGalderma 

“Dermatology is like a pyramid.” The third installment in Galderma’s video series, Beauty x Medicine, Dr. Christoph Martschin, MD Martschin explains how cosmetics, therapeutics and aesthetics all play a key role in building a strong foundation for the skin. Together with our CEO, Flemming Ornskov, MD, MPH Ørnskov, MD, MPH, the Portugal-based dermatologist discusses innovation’s integral role for our field, the latest trends fueling patients’ in-clinic inquiries, and the younger generation’s increased interest in all things skin health. In each episode, Flemming Ørnskov engages with leading experts in dermatology to explore the groundbreaking innovations and fresh perspectives at play when beauty meets medicine. Watch the full episode now and stay tuned for more expert insights coming soon. #AdvancingDermatology #BeautyXMedicine

“What is the most surprising, impactful, or motivating story a patient has told you about their experience with itch or itch resolution?”     We presented this question to the healthcare professionals who visited our interactive ‘Centering On Itch’ booth at European Academy of Dermatology and Venereology's 2024 congress. We were overwhelmed to receive more than 1,500 responses.    Their insights were reviewed and interpreted by an artist to create this powerful mural, depicting some of the ways that itch or itch resolution have impacted the lives of people with diseases like atopic dermatitis and prurigo nodularis. We want to thank everyone involved in bringing this piece to life, as well as all of the doctors who contributed their insights towards the creation of this artwork. It is a striking reminder of the impact itch can have on patients living with these debilitating skin conditions.    #EADV2024  #SkinScienceByGalderma

William’s story is all about regaining confidence. Discover how Sculptra® helped him feel more like himself again.   Always consult a healthcare professional for individualized treatment recommendations and to discuss important safety information and risks associated with the use of the products.

When patients living with prurigo nodularis are asked which symptom they would like to relieve first, an overwhelming majority have the same answer: itch.    In this video, Prof. Sarina Elmariah shares her experience, as a dermatologist and itch specialist, on the burden of itch.      #SkinScienceByGalderma 

We are delighted to share that full results from our phase III clinical trial in #PrurigoNodularis have been published in JAMA Dermatology, reinforcing our leadership in therapeutic dermatology.     Learn more here. https://lnkd.in/eFzZZaq8   #AdvancingDermatology  #SkinScienceByGalderma